Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiproteinuric Effects of Liraglutide in Type 2 Diabetes with Albuminuria
2014-004502-15Phase 4Completed
- Sponsor
- Steno Diabetes Center
- Start
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis and albuminuria comparing Liraglutide with Placebo (2 arms). Primary endpoint: Change in albuminuria. Started Dec 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosisalbuminuria
Beyond the preview
Go deeper on 2014-004502-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004502-15.